Skip to main content
. 2022 Sep 6;14(9):1883. doi: 10.3390/pharmaceutics14091883

Table 2.

Conditions.

Controls PG/cGAMP = Nanocomplexes (NCs)
1/1 or 2/1 PG3/cGAMP 1/1 or 2/1 PG4/cGAMP
cGAMP PG3 PG4 PG3 1/1 or 2/1 PG4 1/1 or 2/1